American Society of Hematology

Fig. 7.

Fig. 7. Probability of survival in patients with AML and patients with MDS following treatment with IA, FA, or TA regimens. / Kaplan-Meier estimates of the proportion of patients with AML (A) and MDS (B) who remain alive following treatment with IA, FA, or TA regimens.

Probability of survival in patients with AML and patients with MDS following treatment with IA, FA, or TA regimens.

Kaplan-Meier estimates of the proportion of patients with AML (A) and MDS (B) who remain alive following treatment with IA, FA, or TA regimens.

This Feature Is Available To Subscribers Only

Sign In or Create an Account